| 000 | 01656 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513201421.0 | ||
| 264 | 0 | _c20000201 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a1525-4135 | ||
| 024 | 7 |
_a10.1097/00126334-199912010-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlston, B | |
| 245 | 0 | 0 |
_aA multicenter, randomized, controlled trial of three preparations of low-dose oral alpha-interferon in HIV-infected patients with CD4+ counts between 50 and 350 cells/mm(3). Division of AIDS Treatment Research Initiative (DATRI) 022 Study Group. _h[electronic resource] |
| 260 |
_bJournal of acquired immune deficiency syndromes (1999) _cDec 1999 |
||
| 300 |
_a348-57 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aEllenberg, J H | |
| 700 | 1 | _aStandiford, H C | |
| 700 | 1 | _aMuth, K | |
| 700 | 1 | _aMartinez, A | |
| 700 | 1 | _aGreaves, W | |
| 700 | 1 | _aKumi, J | |
| 773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 22 _gno. 4 _gp. 348-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00126334-199912010-00005 _zAvailable from publisher's website |
| 999 |
_c10589536 _d10589536 |
||